Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anybody join the class action suit? Any recommendations who to sign up with?
Probably have to return the 1.5 mil to EU partner.
Such a cluster f$ck
There goes Europe for now. At least there's still Asia right...
Europe got taken out of the picture as Sesen withdrew it's Marketing Application due to its reliance on FDA approval.
This is dead money for a good long while.
Jmo
Hi folks, at first let me say I was kicked out @1.80 with a loss. Now in question your discussion abt dilution. As far as I see SESN has Fully Dilutet some 196m shares as they had before the FDA decision took place.Please correct me if I´m wrong. Book Assets abt 50m more than debt. What´s your opinion about any fair value now? I´m not bullish this moment.But there are some other Co´s like ATOS and PHIO suffering the same and now after some time with a nice rebound.Bougth ATOS @3,16 and PHIO for 1,60. Check the actual SP.
If we get an update clarifying things it may go up again after a while,imo. Back in SESN at 0,90 few days ago on speculation trade whith patience.
A valuation on this page shows a fair value of 1.99 with actual numbers - Well, be aware it´s a computer generated number:
https://www.wallstreetzen.com/stocks/us/nasdaq/sesn
I’d be rather shocked if the new GC from Pfizer isn’t working up a pretty solid defense given the discrepancies in the article, timelines, other facts previously made known. Maybe she’s got TC quiet till that’s finished.
Or they’re actually working on supporting info in prep for the FDA meeting.
I believe in the Science. You can always join the lawsuit
How does that help us if we don't receive FDA approval and they're going to dilute this to high hell and squeeze every last penny out of it
Still have Europe and China.
I can't believe anyone is still pumping this as an acquisition stock. The fact is that Tommy boy made out like a villain by diluting this to high hell and cashing out before the news dropped. He played longs like fools. I don't trust the scumbag one bit. He knew exactly what he was doing.
Astra Zenica might just swoop on in and buy 30M as a Strategic Alliance and make their future acquisition THAT much cheaper while lending credibility to Cannell.
Back again. Ill notify the nanny.
A child that is Smarter than YOU !!!
Add this to the CEO's resume. He couldn't get another job in Thailand.
I'm saddened to see legitimate longs get burned here. I was lucky enough to get out around $3 from my $1.01 average.
I am tempted to jump back in and load back up sub dollar but there's too much uncertainty. The CEO is a scumbag and has no trust at this time. Something didn't sit right with me given the insane dilution.
Yes you were right.
Yes again. Thank you Darlin. Very Sweet.
Just watching the trades. They are shorting the hell out of this right here. To each his/her own.
Well thank you Darlin for being so sweet and thinking of me.
Looks like you could sell now and buy back at .50 at the end of today if you want. Falling knife!
I hope it hits .30 today. Lets go
This is now a .30 penny stock. Watch it dip and wait for a buy out.
Cant sell now. Acquisition coming. BOD has to act. Cannell will get the boot.
I do concur. Albeit never sold lol
No. Its FUD. Get ready to purchase for reentry.
Dump away. Lets see .50 Yes, Im on the short side
Good call. Never liked the dilution and at times it seemed a little suspect, but thought not even Sneaky Tom would have the temerity to lie and withhold material information about a clinical trial.
Unfortunately, like other crooked actors he'll get away with it. Those left holding the bag will have to foot the bill here. I'm glad I got out before the news. Something didn't sit right with me about the high dilution and the way it was trading
The alleged clinical trial misconduct puts a whole new context on why Sneaky Tom was always in such a hurry to dilute. Gonna need all that cash on the balance sheet for legal fees, now. And, of course, to pay the fat salaries of him and his cronies while they produce nothing.
Thank you for the reply. Short it is then. Sorry if you were in this when she fell.
The FDA rejection and possible misconduct in the clinical trials has likely set this back at least 12 months and probably more that 24 months. Considering how bad they've been diluting over the last couple of years, I don't expect this to be a winner anytime soon unless there's a buyout offer from another larger company.
Tommy boy diluted this to oblivion in the lead-up to FDA rejection. He knew what he was doing. He already got his money. He now needs this to fall low enough to execute an RS to bring that bloated OS down to something manageable
Any hope for this one or is it a short?
Do you believe that STAT article has any merit and that they truly gave a fraudulent data set to the FDA and investors over the past 3 years? Honest question
The negative FUD coming out about the trial and the mismanagement will take this way under $1. The Board of Directors has to act.
That sounds like the most likely senecio .
So a BP will come in and "fix" the credibility and shares will be $6. The acquirer will then go to trails and score big with this drug.
Patients and those who care about them-
this is what matters.... Using vicinium, the data shows improvement in some sufferers of bladder cancer, doesn't it? If so, then the stock price will improve as well, and that's just my own opinion, regarding the developments over at SESN this week.
Really don’t think that article holds any water. Similar article was put out about NVAX.
If the STAT article is true, Sneaky Tom was more than sneaky. He was fraudulent.
Sorry I’m unable to link it but it’s from benzinga
Sesen Bio's Bladder Cancer Trial Wrecked By Misconduct: Stat News
Mentioned: SESN
Sesen Bio Inc (NASDAQ: SESN) said that it was not expecting a CRL from the FDA for its bladder cancer candidate Vicineum.
But the rejected filing includes several violations and investigator misconduct, STAT News reported.
Related: Sesen Bio Stock Crashes As FDA Shoots Down Its Bladder Cancer Pitch.
The 130-patient study had more than 2,000 violations, 215 classified as major, STAT reported.
Independent monitors also reported three investigators to the FDA for a 'serious noncompliance' that 'placed subjects at risk of harm.'
A patient died in 2016 of liver failure related to the drug, and two years later, the company said that there were no drug-related deaths at a urology conference.
Price Action: SESN shares are down 13.6% at $1.30 during the market session on the last check Wednesday.
Seeking Alpha talks about the trial like some oeople should go to jail. Cheating. Misreporting. Not reporting etc. Cannell and his Oxy pals in deep shizzle.
Anyone see the latest press release. I’d post a link but having tech issues atm
I like your time estimate. Thkx.
Correct - the 18th was the "due by" date for the FDA decision. Sometimes they come down on that date, sometimes they beat it by a couple days.
People would be bitching even more, and with more justification, had SESN received the decision last wekk and held off on the PR until tomorrow.
I thought I read Aug 18 was a TARGETED PDUFA date. I interpret that to mean BY or AROUND 8/18. But I may be wrong.
Sesn pr’s stated fda decision on the 18th. Anyone know when the fda actually said they would issue there decision ?
We’re all expecting it to be on the 18th.and boom 3pm on a Friday we get crushed. I realize that a publicly traded company can not withhold any news like that. But I’d like to know why we where’ll told the 18th
And they hired that entire saleforce? What losers
Followers
|
159
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6939
|
Created
|
07/16/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |